ssociation Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors.
Damato V., Berretta A., Ramanathan S., Michael S., Coupe N., Payne M., Irani SR.
This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.